Treatment of a mouse model of ankylosing spondylitis with exogenous sclerostin has no effect on disease progression
Crossref DOI link: https://doi.org/10.1186/s12891-015-0823-8
Published Online: 2015-11-26
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Haynes, Katelin R.
Tseng, Hsu-Wen
Kneissel, Michaela
Glant, Tibor T.
Brown, Matthew A.
Thomas, Gethin P.